Where medicinal products are authorised for a paediatric indication following completion of an agreed paediatric investigation plan and those products have already been marketed with other indications, the marketing authorisation holder shall, within two years of the date on which the paediatric indication is authorised, place the product on the market taking into account the paediatric indication. A register, coordinated by the Agency, and made publicly available, shall mention these deadlines.
Art. 33 Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 Decembe…
Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 20…Law
… marché dans les deux années suivant la date d’autorisation de l’indication pédiatrique, tel que prévu à l’article 33 du règlement (CE) no 1901/2006. 20. L’obligation de transférer l’autorisation de mise sur le marché ou …
Commission Regulation (EC) No 658/2007 of 14 June 2007 concerning financial penalties fo…1Law
… на разрешението за педиатрична употреба, както е предвидено в член 33 от Регламент (ЕО) № 1901/2006; 26. задължението за прехвърляне на …
… на разрешението за педиатрична употреба, както е предвидено в член 33 от Регламент (ЕО) № 1901/2006; (20) задължението за прехвърляне на …
Commission Regulation (EU) No 488/2012 of 8 June 2012 amending Regulation (EC) No 658/20…1Law
… на разрешението за педиатрична употреба, както е предвидено в член 33 от Регламент (ЕО) № 1901/2006; 26. задължението за прехвърляне на …
Commission Regulation (EU) No 488/2012 of 8 June 2012 amending Regulation (EC) No 658/20…1Law
… on the market within two years of the date on which the paediatric indication is authorised, as provided for in Article 33 of Regulation (EC) No 1901/2006; the obligation to transfer the marketing authorisation or to allow a third party to …
Commission Regulation (EC) No 658/2007 of 14 June 2007 concerning financial penalties fo…1Law
… on the market within two years of the date on which the paediatric indication is authorised, as provided for in Article 33 of Regulation (EC) No 1901/2006; the obligation to transfer the marketing authorisation or to allow a third party to …
Regulation (EU) 2019/5 of the European Parliament and of the Council of 11 December 2018…Law
… use on the market within two years of the date on which the paediatric indication is authorised, as provided for in Article 33 of Regulation (EC) No 1901/2006; the obligation to transfer the marketing authorisation or to allow a third …